sibenadet has been researched along with darifenacin in 2 studies
| Studies (sibenadet) | Trials (sibenadet) | Recent Studies (post-2010) (sibenadet) | Studies (darifenacin) | Trials (darifenacin) | Recent Studies (post-2010) (darifenacin) |
|---|---|---|---|---|---|
| 27 | 7 | 6 | 165 | 28 | 54 |
| Protein | Taxonomy | sibenadet (IC50) | darifenacin (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.3162 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.8322 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 1.5849 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, L; Bailey, A; Cadogan, E; Christie, J; Connolly, S; Cook, AR; Fisher, AJ; Hill, S; Humphries, A; Ingall, AH; Kane, Z; Paine, S; Pairaudeau, G; Stocks, MJ; Young, A | 1 |
| Beattie, D; Beer, D; Bradley, ME; Bruce, I; Charlton, SJ; Cuenoud, BM; Fairhurst, RA; Farr, D; Fozard, JR; Janus, D; Rosethorne, EM; Sandham, DA; Sykes, DA; Trifilieff, A; Turner, KL; Wissler, E | 1 |
2 other study(ies) available for sibenadet and darifenacin
| Article | Year |
|---|---|
Design-driven LO: the discovery of new ultra long acting dibasic β2-adrenoceptor agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Bronchodilator Agents; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; Receptors, Adrenergic, beta-2; Structure-Activity Relationship; Thiazoles | 2011 |
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.
Topics: Adrenergic beta-2 Receptor Agonists; Dose-Response Relationship, Drug; Humans; Indans; Molecular Structure; Quinolones; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2012 |